Camilla Fowst Selected Research

Camilla Fowst Research Topics

Disease

9	Neoplasms (Cancer) 01/2020 - 08/2003
4	Neutropenia 01/2015 - 08/2003
2	Fatigue 01/2021 - 01/2015
2	Disease Progression 01/2020 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2009
1	Nausea 01/2021
1	Exanthema (Rash) 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Carcinoma (Carcinomatosis) 01/2020
1	Body Weight (Weight, Body) 01/2019
1	Hypertension (High Blood Pressure) 01/2018
1	Proteinuria 01/2018
1	Pulmonary Embolism 01/2015
1	Back Pain (Backache) 01/2015
1	Febrile Neutropenia 10/2011
1	Left Ventricular Dysfunction 10/2011
1	Sepsis (Septicemia) 07/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2011
1	Retinoblastoma (Glioblastoma, Retinal) 01/2009
1	Sarcoma (Soft Tissue Sarcoma) 01/2007
1	Turcot syndrome 01/2004

Drug/Important Bio-Agent (IBA)

4	avelumabIBA 01/2021 - 01/2018
4	brostallicinIBA 01/2007 - 08/2003
3	Pharmaceutical PreparationsIBA 01/2018 - 01/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2007 - 08/2003
2	B7-H1 AntigenIBA 01/2021 - 01/2019
2	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 07/2011
2	LigandsIBA 01/2020 - 01/2018
2	Axitinib (AG 013736)IBA 01/2019 - 01/2018
2	palbociclibIBA 01/2015 - 01/2009
1	Gemcitabine FDA Link 01/2020
1	PlatinumIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Sunitinib (Sutent)FDA Link 01/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	Lipase (Acid Lipase)FDA Link 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Apoptosis Regulatory ProteinsIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Amylases FDA Link 01/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2015
1	Letrozole (Femara)FDA LinkGeneric 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2015
1	Cyclin D1IBA 01/2015
1	Cyclin-Dependent Kinase 4IBA 01/2015
1	TransferasesIBA 10/2011
1	Aspartic Acid (Aspartate)FDA Link 10/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2011
1	ProMune (CpG 7909)IBA 07/2011
1	OligodeoxyribonucleotidesIBA 07/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2011
1	Toll-Like Receptor 9IBA 07/2011
1	Phosphotransferases (Kinase)IBA 01/2009
1	Phenobarbital (Luminal)FDA Link 01/2009
1	Estrogen ReceptorsIBA 01/2009
1	Cyclin DIBA 01/2009
1	stallimycinIBA 01/2004
1	Topoisomerase I InhibitorsIBA 01/2004
1	Alkylating AgentsIBA 01/2004

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2007
2	Drug Therapy (Chemotherapy) 01/2020 - 07/2011